Sterling Biotech (Delisted) share news and announcements
BSE: 512299Pharmaceuticals & Biotechnology
Last traded ₹0.70 on 5 Nov 2018
Delisted on 3 Mar 2023.
Sterling Biotech share news and announcements
651 announcements, routine notices left out, newest first. Page 2 of 14.
Jan 2020
17 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....
Dec 2019
21 Dec · Order Of Hon'Ble Supreme Court, New Delhi, Dated 17Th December 2019 - Dairy No. 44707 Of 2019 In Civil Appeal No. 9430/2019 (Arising Out Of Impugned Final Judgment And Order Dated 18-11-2019 In IA No. 2787/2019 Passed By The NCLAT).
Nov 2019
20 Nov · Order Of National Company Law Appellate Tribunal, New Delhi - I.A No. 2787 Of 2019 IN Company Appeal (AT) (Insolvency) No. 612 Of 2019
Oct 2019
30 Oct · Certificate From Practicing Company Secretary For The Half-Year Ended September 30, 2019, As Required Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
23 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....21 Oct · Compliance Certificate As On September 30, 2019 Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
21 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
11 Sep · Corporate Insolvency Resolution Process
10 Sep · Intimation As Per The Requirement Of Regulation 30 Of SEBI (LODR) Regulations, 2015
Jul 2019
20 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....17 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
27 Jun · News Verification
Exchange has sought clarification from Sterling Biotech Limited with respect to news item captioned ED attaches assets worth over Rs 9,000 cr in Sterling Biotech PMLA case. The response from the Company is awaited.27 Jun · Legal
Exchange has sought clarification from Sterling Biotech Ltd with respect to news article appearing on www.dnaindia.com June 26, 2019, titled "ED attaches assets worth over Rs 9,000 ....7 Jun · Intimation As Per The Requirement Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
May 2019
27 May · Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
16 May · Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP)
13 May · Legal
Exchange has sought clarification from the Company with respect to news item captioned- titled "RBI found irregularities in guarantees to Sterling Bio". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is awaited.13 May · Legal
Exchange has sought clarification from Sterling Biotech Ltd with respect to news article appearing on www.dnaindia.com May 13, 2019 titled "RBI found irregularities in bank guarantees ....
Apr 2019
25 Apr · Certificate From Practicing Company Secretary For The Half Year Ended March 31, 2019, As Required Under Regulation 40 (9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
19 Apr · Compliance Certificate As On March 31, 2019 Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
18 Apr · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....18 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Apr · Management
12 Apr · Update On The Outcome Of The 15Th Meeting Of The Committee Of Creditors ('Coc') Of Sterling Biotech Limited Held On 08Th April 2019
9 Apr · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Mar 2019
8 Mar · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
6 Mar · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
6 Mar · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
4 Mar · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
3 Mar · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Feb 2019